MAY 01, 2018 12:00 PM PDT

CNS Tumor Cells Destroyed by Zika Virus

Central Nervous System (CNS) tumors have historically be categorized though histopathology (a microscope-based approach).  Tumors are surgically removed and then biopsied to determine a diagnosis, prognosis, and treatment determinations.  With advances in molecular and genetic profiling of tumors, researchers and providers found that the combination of CNS tumor biodiversity and their unique molecular markers really define brain tumor types.  The World Health Organization (WHO) reclassified CNS tumors in 2016 based on this information.  There are additional recognized entities based on variants and patterns in Glioblastomas and Ganglion Cell tumors for example.  An “integrated diagnosis”, based on the new edition of WHO brain tumor classifications will be more precise and include: histological diagnosis, WHO histological grade, and molecular information.

The changes in the WHO classification have helped provide guidance on molecular markers that can be targets of new immunotherapies.  It helps differentiate the cellular makeup of particular tumors that could not be determined prior. 

On April 26, 2018, a Brazilian study was published in the journal Cancer Research utilizing the Zika Virus to kill CNS tumor cells.  The group focused their work on embryonal CNS tumors because these are found to be aggressive and reveal themselves close to birth or in early adolescence.  These are fast growing tumors that cause damage as the CNS is developing in a child.  The researchers focused initially on Zika because it infects and destroys neural stem cells in the fetus and prevents the formation of new neurons.  While not fully understood, it is suspected that Zika targets the neural stem cell surface marker AXL.  They wondered if the virus could attack tumor stem cells in the CNS, given its modus operandi in healthy tissue.

They examined the effects of Zika on three human tumor cell lines derived from medulloblastoma and atypical teratoid/rhabdoid tumors (AT/RT).  These cancers are caused by stem cell DNA aberrations and affect neural progenitor cells during development and cellular maturation processes.  The group also infected other tumor cell line types from breast, prostate, and colorectal cancers as a comparative to neural tissue tumor effects.

Results showed that even small amounts of Zika virus were enough to infect CNS tumor cells.  In far fewer numbers, prostate cells were infected.  No amount of Zika used in the experiment was enough to induce infection of breast or colorectal cancer cells. 

The group also examined the comparative capacity of Zika to infect CNS tumor cells and healthy neural stem cells.  Surprisingly, the CNS tumor cells were more susceptible to destruction by Zika than the healthy stem cells.  The AT/RT tumor cell line was: 1. most sensitive to infection and, 2. the closest in molecular resemblance to healthy neural stem cells.  The group also found that upon initial examination, Zika can also infect and kill other kinds of CNS tumor types including glioblastoma.

More research must be done to continue developing the potential of using Zika to destroy CNS tumors while not damaging healthy brain tissue in vivo; we have seen the consequences of this virus painfully manifested in children born in the very recent past, so it is prudent to consider how to meaningfully use Zika in a controlled way.

Sources: Cancer Research, Sao Paulo Research Foundation, National Brain Tumor Society,

About the Author
  • Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education from the University of Minnesota. She has worked in the clinical laboratory, taught at the University of Minnesota, and been in post secondary healthcare education administration. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
JUN 19, 2018
Cancer
JUN 19, 2018
Cancer-Related Cognitive Impairment aka "ChemoBrain" Needs YOU!
There is a need for neuroscientists to investigate what is known as chemobrain; survivors and providers are looking for ideas for approaches to mitigating this late effect chemo related issue...
JUL 10, 2018
Cancer
JUL 10, 2018
New Potential Inhibitor Target for Mantle Cell Lymphoma
A new small molecule inhibitor, called PTC596, initiated apoptosis in MCL cells according to a study published this month in Oncotarget....
JUL 24, 2018
Cancer
JUL 24, 2018
Transfection, Transduction, and CRISPR...Oh My
CRISPR gene editing came about based on transfection and transduction type models of genetic transfer. There is potential for it to revolutionize gene editing but are there dangers lurking?...
AUG 07, 2018
Cancer
AUG 07, 2018
Can a Myeloid Marker Be Helpful in B-cell Neoplasm Diagnostic Testing?
A group of US researchers have identified CD13 in certain subtypes of B-cell neoplasms, thereby aiding in a more detailed diagnosis....
SEP 26, 2018
Videos
SEP 26, 2018
Cancer Immunotherapy
Video illustration about how tumor cells are sensed and destroyed by the immune system and how tumors evolve and detect immune-mediated eliminations, as well as iimmunotherapies associated....
OCT 17, 2018
Cell & Molecular Biology
OCT 17, 2018
Saving Patients From Unnecessary Chemotherapy with a Blood Test
Often, cancer patients get chemotherapy after surgery to ensure that their cancer will not come back; for many it's not needed....
Loading Comments...